US33749P4081 - Common Stock
FIRST WAVE BIOPHARMA
NASDAQ:FWBI (3/27/2024, 8:15:37 PM)
Premarket: 3.98 +0.03 (+0.76%)3.95
-0.02 (-0.5%)
First Wave BioPharma Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Boca Raton, Florida and currently employs 10 full-time employees. The company went IPO on 2016-10-11. First Wave BioPharma, Inc. is a clinical-stage biopharmaceutical company. The firm is engaged in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal (GI) diseases. The company is focused on developing its pipeline of gut-restricted GI clinical drug candidates, including the biologic adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients, and niclosamide, which is an oral small molecule with anti-viral and anti-inflammatory properties. Its adrulipase programs are focused on the development of an oral, non-systemic, biologic capsule for the treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis and chronic pancreatitis. The company is advancing two separate Phase 2 clinical programs of its niclosamide formulations, including FW-COV for Severe Acute Respiratory Syndrome Coronavirus 2 GI infections, and FW-UP for ulcerative proctitis and ulcerative proctosigmoiditis.
FIRST WAVE BIOPHARMA
777 Yamato Road, Suite 502
Boca Raton FLORIDA
P: 15615897020
CEO: James Sapirstein
Employees: 10
Website: https://www.firstwavebio.com
Poster presentations to highlight new quantitative and serologic diagnostic methods for Celiac Disease detection and determination of intestinal mucosal...
Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.
Fisker stock is falling hard on Thursday as FSR investors react to reports that the EV company is preparing to file for bankruptcy.
Spruce Biosciences stock is falling hard on Thursday as investors in SPRB shares react to the latest clinical trial data reported.
First Wave BioPharma stock is up on Thursday as FWBI investors celebrate the company completing its business combination with ImmunogenX.
It's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
Here you can normally see the latest stock twits on FWBI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: